Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib + Artemether/Lumefantrine for Uncomplicated Malaria
NCT07559370Phase 2Recruiting
- Sponsor
- Victoria Biomedical Research Institute
- Start
- Jan 2026
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of imatinib in malaria, sponsored by Victoria Biomedical Research Institute. Started Jan 2026; status: recruiting.
02
Drugs
03
Conditions
malaria
Beyond the preview
Go deeper on NCT07559370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07559370.